Listed

Protalix BioTherapeutics, Inc.

PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31

Reports and events: 399 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Protalix BioTherapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2012-06-2507:42 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-12-036152
2012-06-2208:50 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-035911
2012-06-1816:57 ET8-K5.07 Shareholder vote results0001144204-12-035275
2012-06-1107:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-034096
2012-05-2907:36 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-12-032099
2012-05-2108:12 ETDEF 14AProxy statementPeriod 2012-06-170001144204-12-030772
2012-05-1007:34 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-12-027345
2012-05-0916:33 ET10-QQuarterly reportPeriod 2012-03-310001144204-12-027198
2012-05-0206:03 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-025455
2012-03-1917:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-12-015923
2012-02-2716:13 ET10-KAnnual reportPeriod 2011-12-310001144204-12-011082
2012-02-2307:35 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-010509
2012-02-1617:06 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-009665
2012-02-1516:20 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-009380
2012-02-0906:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-12-006728
2012-01-2606:13 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-12-003991
2011-12-1316:24 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-11-069608
2011-12-0607:40 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-11-068460
2011-12-0106:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-11-067780
2011-11-1007:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-11-062742
2011-11-0816:09 ET8-K5.07 Shareholder vote results0001144204-11-062019
2011-11-0716:09 ET10-QQuarterly reportPeriod 2011-09-300001144204-11-061636
2011-10-2607:44 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-11-059337
2011-09-2107:54 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-11-054042
2011-09-1916:42 ETDEF 14AProxy statementPeriod 2011-11-070001144204-11-053749
2011-09-1317:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-11-052800
2011-09-0808:23 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-11-051725
2011-08-1708:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-11-048074
2011-08-0806:04 ET10-QQuarterly reportPeriod 2011-06-300001144204-11-044353
2011-08-0109:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-11-043025
2011-06-1516:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-11-035916
2011-05-1216:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-11-049414
2011-05-0417:27 ET10-QQuarterly reportPeriod 2011-03-310000950123-11-044803
2011-04-2716:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-11-040029
2011-04-0716:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-11-033732
2011-03-2316:05 ET8-K/A9.01 Financial statements and exhibits0000950123-11-028238
2011-03-1806:02 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0000950123-11-026581
2011-03-1716:18 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-11-026403
2011-02-2506:39 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-11-018222
2011-02-2317:19 ET10-KAnnual reportPeriod 2010-12-310000950123-11-017213
2011-02-1813:26 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-11-015571
2011-01-2711:27 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-11-005907
2011-01-2417:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-11-004909
2011-01-2016:18 ETSC 13D/AOwnership report, active investor, amended0001144204-11-003118
2011-01-1909:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-11-003615
2011-01-0408:22 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950123-11-000165
2010-11-2916:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-109328
2010-11-1016:47 ET8-K5.07 Shareholder vote results0000950123-10-103946
2010-11-0816:42 ET10-QQuarterly reportPeriod 2010-09-300000950123-10-102510
2010-11-0206:25 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-099118

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.